Browse studies, page 6
Page 6 of 1,159, newest first. Search them all at once, ranked by relevance, in Evidence Hub.
- Design, synthesis, and biological evaluation of 2-phenylthiazole CYP51 inhibitors RSC medicinal chemistry, 2025
- In vitro profiling of Trypanosoma cruzi inhibitors identified from High throughput Screening and application to parasite painting International journal for parasitology. Drugs and drug resistance, 2026
- The pipeline for drugs for control and elimination of neglected tropical diseases: 2. Oral anti-infective drugs and drug combinations for off-label use Parasites & vectors, 2023
- Dual‐Targeting, Hybrid Antifungal Agents Targeting Candida albicans —An Overview Chemical biology & drug design, 2026
- Diagnostic capacities and treatment practices on implantation mycoses: Results from the 2022 WHO global online survey PLoS neglected tropical diseases, 2023
- In vitro and in vivo studies on the activity and selectivity of butoconazole in experimental infection by Trypanosoma cruzi Memorias do Instituto Oswaldo Cruz, 2025
- Neglected tropical diseases: recent trends and challenges associated with its rapid diagnosis and effective therapeutic strategies Frontiers in pharmacology, 2026
- Eumycetoma causative agents are inhibited in vitro by luliconazole, lanoconazole and ravuconazole Mycoses, 2022
- Tinea Incognito Imitating Pustular Psoriasis in a Psoriatic Patient Following Immunosuppressive Therapy: Case Report and Narrative Review Journal of clinical medicine, 2026
- The Outcome of Aplastic Anaemia Associated with Terbinafine Therapy European journal of case reports in internal medicine, 2024
- Newer Therapies in Dermatophytosis Indian journal of dermatology, 2023
- Clinical Isolate of a Multi-Antifungal-Resistant Trichophyton rubrum Antimicrobial agents and chemotherapy, 2022
- Emerging Terbinafine Resistant Trichophyton Dermatophytosis, Testing Options and Alternative Treatments: A Systematic Review The Australasian journal of dermatology, 2025
- Parasitic diseases in heart transplantation: challenges of Toxoplasmosis and Chagas Disease JHLT open, 2026
- A global chromoblastomycosis strategy and development of the global chromoblastomycosis working group PLoS neglected tropical diseases, 2024
- In vitro susceptibility profiles of 16 antifungal drugs against Trichophyton indotineae Microbiology spectrum, 2025
- Stress-Activated Protein Kinase Pathways as Potential Targets for the Development of New Antifungals Journal of fungi (Basel, Switzerland), 2026
- Multitarget Therapeutic Strategies for Chagas Disease: Natural Compounds, Antimicrobial Peptides, and Cell-Based Immunomodulation Infectious disease reports, 2026
- Advances and challenges in the search for new treatments for Chagas disease Memorias do Instituto Oswaldo Cruz, 2026
- Evaluation of Clinical Studies of Patients With Dermatophyte Infections Caused by Trichophyton indotineae: Treatment Response and Resistance to Antifungal Medications Dermatology practical & conceptual, 2025
- A drug-repurposing screen of FDA- and EMA-approved drugs identifies two NF-κB inhibitors active against eumycetoma The Journal of antimicrobial chemotherapy, 2025
- Early assessment of antibodies decline in Chagas patients following treatment using a serological multiplex immunoassay Nature communications, 2024
- Repurposing FDA-Approved Drugs for Eumycetoma Treatment: Homology Modeling and Computational Screening of CYP51 Inhibitors International journal of molecular sciences, 2025
- The efficacy and safety of benznidazole in adults with seropositive indeterminate form, Trypanosoma cruzi infection: a systematic review and meta-analysis BMC infectious diseases, 2025
- Quantifying anti-trypanosomal treatment effects in chronic indeterminate Chagas disease: an individual patient data meta-analysis of two proof of concept trials medRxiv, 2024
- A Strategic Partnership for Medicine Creation and Access to Medicine for Neglected Tropical Diseases Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2022
- Using (1,3)‐ β‐D ‐glucan concentrations in serum to monitor the response of azole therapy in patients with eumycetoma caused by Madurella mycetomatis Mycoses, 2024
- Widespread Majocchi's Granuloma Caused by Multidrug-Resistant Trichophyton rubrum Successfully Treated With Amphotericin B and Posaconazole The Journal of dermatology, 2025
- Epidemiological cut-off values for itraconazole and ravuconazole for Madurella mycetomatis, the most common causative agent of mycetoma Mycoses, 2022
- Onychomycosis caused by Aspergillus species belonging to section Circumdati The Journal of dermatology, 2025
- Receipt survey of prescription continuation rates for patients with onychomycosis and web-based survey of dermatologists on prescribing policies for onychomycosis therapeutics The Journal of dermatology, 2024
- A balancing act: Navigating the advantages and challenges of pioneering mycetoma treatment in Sudan-A landmark trial by the Mycetoma Research Center PLoS neglected tropical diseases, 2025
- Advances in the treatment of mycetoma: the emerging role of nanomedicine Nanomedicine (London, England), 2026
- The Current Landscape of Repurposed Drugs for Fungal Neglected Tropical Diseases Current fungal infection reports, 2025
- Fungal melanonychia caused by Candida parapsilosis successfully treated with oral fosravuconazole The Journal of dermatology, 2019
- Assessing anti-T. cruzi candidates in vitro for sterile cidality International journal for parasitology. Drugs and drug resistance, 2016
- Onychomycosis in Older Adults: Prevalence, Diagnosis, and Management Drugs & aging, 2022
- Topical Luliconazole Treatment for Hyperkeratotic Tinea Pedis Mycopathologia, 2025
- Impact of new antifungal medications on onychomycosis prescriptions and costs in Japan: A nationwide claims database study The Journal of dermatology, 2024
- High multi-azole-resistant Malassezia pachydermatis clinical isolates from canine Malassezia dermatitis Medical mycology, 2020
- Clinical Management of Antifungal-Resistant Dermatophytosis in Japan Medical mycology journal, 2026
- Monotherapy and combination chemotherapy for Chagas disease treatment: a systematic review of clinical efficacy and safety based on randomized controlled trials Parasitology, 2022
- Exploratory study on short-term administration of oral fosravuconazole for tinea pedis The Journal of dermatology, 2025
- Quantifying anti-trypanosomal treatment effects in chronic indeterminate Chagas disease: a secondary analysis of individual patient data from two proof-of-concept trials The Lancet. Microbe, 2025
- Dermatophytomas in Onychomycosis: A Scoping Review of Prevalence, Diagnosis, and Treatment Journal of the American Podiatric Medical Association, 2024
- Emerging Antifungal-Resistant Onychomycosis in a Dermatology Clinic in Kumamoto, Japan Medical mycology journal, 2025
- Fosravuconazole to treat severe onychomycosis in the elderly The Journal of dermatology, 2021
- Empiric antifungal therapy in patients with cutaneous and subcutaneous phaeohyphomycosis The Journal of dermatology, 2022
- Evaluation of Hepatic and Renal Function Algorithms for Fosravuconazole in Real-World Clinical Practice Medical mycology journal, 2026
- Safety and efficacy of new generation azole antifungals in the management of recalcitrant superficial fungal infections and onychomycosis Expert review of anti-infective therapy, 2024
- Transplantation for chagas' disease: closing the knowledge gap Current opinion in infectious diseases, 2022
- Review on Experimental Treatment Strategies Against Trypanosoma cruzi Journal of experimental pharmacology, 2021
- Long-term follow-up study of the efficacy of fosravuconazole in the treatment of onychomycosis in elderly patients The Journal of dermatology, 2024
- Population pharmacokinetic-pharmacodynamic analysis of benznidazole monotherapy and combination therapy with fosravuconazole in chronic Chagas disease (BENDITA) PLoS neglected tropical diseases, 2025
- Review of the alternative therapies for onychomycosis and superficial fungal infections: posaconazole, fosravuconazole, voriconazole, oteseconazole International journal of dermatology, 2022
- Pharmacokinetics and Pharmacodynamics of Fosravuconazole, Itraconazole, and Hydroxyitraconazole in Sudanese Patients With Eumycetoma The Journal of infectious diseases, 2025
- Onychomycosis: a review Journal of the European Academy of Dermatology and Venereology : JEADV, 2020
- Germline-encoded amino acid-binding motifs drive immunodominant public antibody responses Science, 2023
- Decrease in sleep depth is associated with higher cerebrospinal fluid neurofilament light levels in Alzheimer's disease patients Sleep, 2020
- Characterization of KMT2A::MATR3 fusion in a patient with acute lymphoblastic leukemia and monitoring of minimal residual disease by nanoplate digital PCR Pediatric Blood & Cancer, 2022
- Steric Clash in the SET Domain of Histone Methyltransferase NSD1 as a Cause of Sotos Syndrome and Its Genetic Heterogeneity in a Brazilian Cohort Genes, 2016
- 6870 Cardiac Imaging And Metabolomics Studies Suggest Differential Risk And Protective Biomarkers For Cardiovascular Disease In Renoprotected, Long-Duration Type 1 Diabetes Journal of the Endocrine Society, 2024
- A prospective study of soluble receptor for advanced glycation end-products and colorectal cancer risk in postmenopausal women Cancer Epidemiology, 2016
- The Appetite−Suppressant and GLP-1-Stimulating Effects of Whey Proteins in Obese Subjects are Associated with Increased Circulating Levels of Specific Amino Acids Nutrients, 2020
- Abstract 1736: Elucidating the oncogenic mechanisms in diffuse midline glioma: Comparative analysis of h3k27m mutation and k27 methylation loss on gene expression profiles via RNA sequencing Cancer Research, 2024
- Flucloxacillin Hypersensitivity: Patient Outcomes in a Multicenter Retrospective Study Journal of Allergy and Clinical Immunology: In Practice, 2019
- Protection From Retinopathy and Other Complications in Patients With Type 1 Diabetes of Extreme Duration Diabetes Care, 2011
- Circulating selenium and carboxymethyl-lysine, an advanced glycation end product, are independent predictors of anemia in older community-dwelling adults Nutrition (Burbank, Los Angeles County, Calif.), 2012
- BNT162b2 mRNA vaccination affects the gut microbiome composition of patients with follicular lymphoma and chronic lymphocytic leukemia Biomarker Research, 2025
- Left Ventricular Remodeling Predictors in Chronic Heart Failure of Ischemic Etiology Kardiologiia, 2024
- 322-OR: Delaying Progression of Diabetic Retinopathy Worsens the Risk for Age-Related Macular Degeneration Diabetes, 2024
- Plasma Levels of Advanced Glycation Endproducts and Risk of Cardiovascular Events: Findings From 2 Prospective Cohorts Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease, 2022
- The effects of inhaled aztreonam on the cystic fibrosis lung microbiome Microbiome, 2017
- Metabolomics Profiles and Prognostic Biomarkers in Sepsis Survivors and Nonsurvivors Journal of Surgical Research, 2026
- The integration of plasma non-target metabolomics and lipidomics analysis for the discovery of global developmental delay/intellectual disability biomarkers Frontiers in Cellular Neuroscience, 2026
- Integrated Multiomics Reveals Gut–Brain Axis Dysregulation and Phenotype-Specific Metabolic Signatures in Children with Febrile Seizures Biomedicines, 2026
- SETD1B-associated neurodevelopmental disorder Journal of Medical Genetics, 2020
- MSL2 variants lead to a neurodevelopmental syndrome with lack of coordination, epilepsy, specific dysmorphisms, and a distinct episignature American Journal of Human Genetics, 2024
- Epigenetic regulators of clonal hematopoiesis control CD8 T cell stemness during immunotherapy Science, 2024
- Integrated nasopharyngeal airway metagenome and asthma genetic risk endotyping of severe bronchiolitis in infancy and risk of childhood asthma European Respiratory Journal, 2024
- Development and Validation of a Novel Plasma Metabolomic Signature for the Detection of Renal Cell Carcinoma European Urology, 2025
- From CDK4/6 to CDK2 and KAT: Evolving therapeutic approaches in HR+/HER2– breast cancer Breast, 2026
- Advanced Glycation/Glycoxidation Endproduct Carboxymethyl-Lysine and Incidence of Coronary Heart Disease and Stroke in Older Adults Atherosclerosis, 2014
- NIMBLE: A Phase I/II Study of AZD0466 Monotherapy or in Combination in Patients with Advanced Hematological Malignancies Blood, 2021
- Pulmonary Outcomes Associated with Long-Term Azithromycin Therapy in Cystic Fibrosis American Journal of Respiratory and Critical Care Medicine, 2020
- Revumenib Monotherapy in Patients with Relapsed/Refractory KMT2Ar Acute Leukemias: Efficacy and Safety Results from the Augment-101 Phase 1/2 Study Blood, 2023
- Multiomics Analysis of Plasma Proteomics and Metabolomics of Steroid Resistance in Childhood Nephrotic Syndrome Using a “Patient-Specific” Approach Kidney International Reports, 2023
- Untargeted metabolomics identifies trimethyllysine, a TMAO-producing nutrient precursor, as a predictor of incident cardiovascular disease risk JCI Insight, 2018
- Comparative CKD risk prediction using homocitrulline and carbamylated albumin: two circulating markers of protein carbamylation BMC Nephrology, 2024
- Habitual intake of dietary L-arginine in relation to risk of type 2 diabetes: a prospective study BMC Endocrine Disorders, 2021
- Dietary intake of advanced glycation endproducts is associated with higher levels of advanced glycation endproducts in plasma and urine: The CODAM study Clinical Nutrition, 2017
- Hepatic Fat Content and Liver Enzymes Are Associated with Circulating Free and Protein-Bound Advanced Glycation End Products, Which Are Associated with Low-Grade Inflammation: The CODAM Study Journal of Diabetes Research, 2019
- Bomedemstat (MK3543) in Combination with Ruxolitinib in Patients with Advanced Myelofibrosis Blood, 2024
- The Human Ocular Surface Microbiome and Its Associations with the Tear Proteome in Dry Eye Disease International Journal of Molecular Sciences, 2023
- Higher dietary advanced glycation products intake is associated with increased risk of dementia, independent from genetic predisposition Clinical Nutrition, 2023
- Menin Inhibition With Revumenib for KMT2A-Rearranged Relapsed or Refractory Acute Leukemia (AUGMENT-101) Journal of Clinical Oncology, 2024
- Identification of pyruvic and maleic acid as potential markers for disease activity and prognosis in chronic urticaria Journal of Allergy and Clinical Immunology, 2024
- Updated Results and Longer Follow-up from the AUGMENT-101 Phase 2 Study of Revumenib in All Patients with Relapsed or Refractory (R/R) KMT2Ar Acute Leukemia Blood, 2024
- Integrated proteomic and metabolomic profiling reveals sex‐stratified biomarkers predicting chronicity in paediatric primary immune thrombocytopenia British Journal of Haematology, 2026
- Metabolomic machine learning predictor for the diagnosis of aspiration pneumonia European Journal of Medical Research, 2026
